vs
Side-by-side financial comparison of EyePoint, Inc. (EYPT) and Precipio, Inc. (PRPO). Click either name above to swap in a different company.
Precipio, Inc. is the larger business by last-quarter revenue ($6.8M vs $5.3M, roughly 1.3× EyePoint, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -1114.3%, a 1122.0% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -43.7%). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-63.8M). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -40.8%).
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.
EYPT vs PRPO — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.3M | $6.8M |
| Net Profit | $-59.4M | $526.0K |
| Gross Margin | — | 45.9% |
| Operating Margin | -1166.8% | 7.9% |
| Net Margin | -1114.3% | 7.7% |
| Revenue YoY | -43.7% | 28.4% |
| Net Profit YoY | -92.8% | 244.1% |
| EPS (diluted) | $-0.85 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.8M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | $5.3M | $5.6M | ||
| Q1 25 | $24.5M | $4.9M | ||
| Q4 24 | $11.6M | $5.3M | ||
| Q3 24 | $10.5M | $5.3M | ||
| Q2 24 | $9.5M | $4.5M | ||
| Q1 24 | $11.7M | $3.5M |
| Q4 25 | — | $526.0K | ||
| Q3 25 | — | $-79.0K | ||
| Q2 25 | $-59.4M | $74.0K | ||
| Q1 25 | $-45.2M | $-884.0K | ||
| Q4 24 | $-41.4M | $-365.0K | ||
| Q3 24 | $-29.4M | $-626.0K | ||
| Q2 24 | $-30.8M | $-1.2M | ||
| Q1 24 | $-29.3M | $-2.1M |
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 43.6% | ||
| Q2 25 | — | 43.2% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 49.8% | ||
| Q3 24 | 93.0% | 43.1% | ||
| Q2 24 | 85.2% | 38.1% | ||
| Q1 24 | 93.5% | 26.5% |
| Q4 25 | — | 7.9% | ||
| Q3 25 | — | -0.9% | ||
| Q2 25 | -1166.8% | -14.6% | ||
| Q1 25 | -199.7% | -17.5% | ||
| Q4 24 | -390.4% | -6.3% | ||
| Q3 24 | -311.2% | -11.3% | ||
| Q2 24 | -364.5% | -26.8% | ||
| Q1 24 | -285.2% | -59.6% |
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | -1.1% | ||
| Q2 25 | -1114.3% | 1.3% | ||
| Q1 25 | -184.8% | -18.0% | ||
| Q4 24 | -357.3% | -6.9% | ||
| Q3 24 | -279.0% | -11.9% | ||
| Q2 24 | -325.3% | -27.1% | ||
| Q1 24 | -250.6% | -59.8% |
| Q4 25 | — | $0.36 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | $-0.85 | $0.05 | ||
| Q1 25 | $-0.65 | $-0.59 | ||
| Q4 24 | $-0.65 | $-0.22 | ||
| Q3 24 | $-0.54 | $-0.42 | ||
| Q2 24 | $-0.58 | $-0.83 | ||
| Q1 24 | $-0.55 | $-1.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $255.7M | $2.7M |
| Total DebtLower is stronger | — | $83.0K |
| Stockholders' EquityBook value | $246.0M | $14.6M |
| Total Assets | $301.1M | $21.3M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.7M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | $255.7M | $1.1M | ||
| Q1 25 | $318.2M | $1.0M | ||
| Q4 24 | $370.9M | $1.4M | ||
| Q3 24 | $253.8M | $1.1M | ||
| Q2 24 | $280.2M | $1.3M | ||
| Q1 24 | $299.3M | $776.0K |
| Q4 25 | — | $83.0K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $383.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $14.6M | ||
| Q3 25 | — | $13.7M | ||
| Q2 25 | $246.0M | $12.3M | ||
| Q1 25 | $298.4M | $11.7M | ||
| Q4 24 | $336.5M | $12.1M | ||
| Q3 24 | $218.7M | $11.9M | ||
| Q2 24 | $228.3M | $12.1M | ||
| Q1 24 | $249.9M | $12.8M |
| Q4 25 | — | $21.3M | ||
| Q3 25 | — | $21.2M | ||
| Q2 25 | $301.1M | $18.8M | ||
| Q1 25 | $362.6M | $17.8M | ||
| Q4 24 | $418.5M | $17.0M | ||
| Q3 24 | $300.9M | $17.0M | ||
| Q2 24 | $324.2M | $17.3M | ||
| Q1 24 | $329.2M | $16.6M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-62.6M | $366.0K |
| Free Cash FlowOCF − Capex | $-63.8M | $291.0K |
| FCF MarginFCF / Revenue | -1196.5% | 4.3% |
| Capex IntensityCapex / Revenue | 22.9% | 1.1% |
| Cash ConversionOCF / Net Profit | — | 0.70× |
| TTM Free Cash FlowTrailing 4 quarters | $-194.0M | $359.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $366.0K | ||
| Q3 25 | — | $10.0K | ||
| Q2 25 | $-62.6M | $353.0K | ||
| Q1 25 | $-53.1M | $-44.0K | ||
| Q4 24 | $-35.8M | $565.0K | ||
| Q3 24 | $-39.0M | $41.0K | ||
| Q2 24 | $-20.2M | $500.0K | ||
| Q1 24 | $-31.2M | $-667.0K |
| Q4 25 | — | $291.0K | ||
| Q3 25 | — | $-44.0K | ||
| Q2 25 | $-63.8M | $294.0K | ||
| Q1 25 | $-53.4M | $-182.0K | ||
| Q4 24 | $-36.2M | — | ||
| Q3 24 | $-40.6M | $-68.0K | ||
| Q2 24 | $-21.1M | — | ||
| Q1 24 | $-32.4M | — |
| Q4 25 | — | 4.3% | ||
| Q3 25 | — | -0.6% | ||
| Q2 25 | -1196.5% | 5.2% | ||
| Q1 25 | -218.4% | -3.7% | ||
| Q4 24 | -312.7% | — | ||
| Q3 24 | -385.8% | -1.3% | ||
| Q2 24 | -222.4% | — | ||
| Q1 24 | -277.0% | — |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | 22.9% | 1.0% | ||
| Q1 25 | 1.1% | 2.8% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 15.0% | 2.1% | ||
| Q2 24 | 9.5% | — | ||
| Q1 24 | 10.2% | — |
| Q4 25 | — | 0.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
